Xolair (omalizumab) has an average elimination half-life of 26 days in asthma patients and 24 days in those treated for chronic hives. That means it takes roughly 4 to 5 months after your last injection for the drug to fully clear your body. Because Xolair is a large antibody-based molecule injected under the skin, it moves through your system much more slowly than a typical pill.
What the Half-Life Means in Practice
A half-life of 26 days means that every 26 days, the concentration of Xolair in your blood drops by half. After one month, about half the drug remains. After two months, roughly a quarter. Pharmacologists generally consider a drug “out of your system” after about five half-lives, which for Xolair works out to approximately 130 days, or a little over four months.
This is unusually long compared to most medications. The reason is that Xolair is a monoclonal antibody, a large protein that your body breaks down gradually rather than filtering it out quickly through the liver or kidneys. After a single injection, the drug is absorbed slowly, reaching its peak blood concentration around 7 to 8 days later. If you’ve been receiving regular injections for months, the drug accumulates to about six times the level of a single dose, so the total clearance window after your final injection may stretch closer to five or even six months.
When Symptoms Typically Return
Xolair works by binding to IgE, the immune molecule responsible for allergic reactions and hives. While the drug is circulating, free IgE levels in your blood stay low. Once you stop treatment, free IgE gradually rises back toward your pre-treatment baseline as Xolair concentrations decline.
Symptom return doesn’t happen the moment IgE starts climbing. Research tracking asthma patients after discontinuation found a noticeable delay between rising IgE levels and worsening symptoms. Your lungs and skin don’t react instantly to changing IgE; there’s a physiological lag as the inflammatory cascade ramps back up. In practical terms, many people feel fine for several weeks after their last injection, then notice a gradual return of symptoms over the following one to three months. The timeline varies depending on the severity of your underlying condition and how long you were on treatment.
There is also some evidence that long-term Xolair use may reduce IgE production itself, not just block existing IgE. How long that effect persists after stopping is still unclear, but it could mean some people experience a longer symptom-free window than the drug’s clearance alone would predict.
Factors That Affect Clearance Speed
Not everyone clears Xolair at the same rate. The two biggest variables are body weight and baseline IgE levels.
- Body weight: Xolair’s clearance scales almost directly with how much you weigh. A heavier person clears the drug faster in absolute terms, which is why dosing is adjusted by weight. The average clearance rate is about 2.4 mL/kg/day for asthma patients. A person weighing 80 kg (about 176 pounds) clears roughly 240 mL of drug-containing fluid per day.
- Baseline IgE: People with higher pre-treatment IgE levels form more drug-IgE complexes, which are cleared from the body at their own rate. Higher IgE can shift the balance of how much drug is “free” versus bound, subtly influencing how long active drug circulates.
Age, gender, and ethnicity do not significantly change the drug’s clearance rate. Pediatric patients (ages 6 and up) show pharmacokinetic profiles comparable to adults when weight-adjusted dosing is used, so children clear the drug on a similar timeline relative to their size.
Why This Matters for Allergy Testing
One common reason people ask about Xolair’s clearance is allergy skin testing. Because Xolair suppresses free IgE, it can dampen the skin’s allergic response and produce falsely negative results. Free IgE drops within days of starting treatment, but it takes months after stopping for levels to recover enough for reliable testing. If you need allergy skin testing or blood-based specific IgE testing, plan for a waiting period that accounts for the drug’s long elimination window.
What “Out of Your System” Really Looks Like
The 4-to-5-month clearance estimate describes when measurable drug levels drop below detection. But the practical effects fade on a different schedule. Xolair loses its therapeutic punch well before it’s completely gone, because as concentrations fall below a certain threshold, there isn’t enough drug left to keep IgE adequately suppressed. That threshold varies by person, but most people will notice a meaningful change in symptom control within 2 to 3 months of their last dose, even though trace amounts of the drug persist longer.
If you’re transitioning off Xolair or switching treatments, this gradual decline gives you and your care team a window to adjust. The drug doesn’t drop off a cliff; it tapers steadily, giving your body time to readjust to its natural IgE levels.